A Study of Escalating Doses of DCDS0780A in Participants With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

Clinical trial NCT02453087 · COMPLETED

Trial details

NCT number: NCT02453087
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Hodgkin's Lymphoma

Start date: 2015-08-04
Primary completion: 2019-07-12
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.